4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000133
Chairperson & CEO sold 9,500 shares at an average $514.09 ($4,883,839)
- Chairperson & CEO acquired 9,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
8 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-01 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,500 | $135.42 | $1,286,490 | 333,943 | I |
| 2026-09-01 | Sale : show line 2 in the form 10b5-1 | −320 | $510.72 | $163,432 | 333,623 | I |
| 2026-09-01 | Sale : show line 3 in the form 10b5-1 | −825 | $511.95 | $422,359 | 332,798 | I |
| 2026-09-01 | Sale : show line 4 in the form 10b5-1 | −1,732 | $513.12 | $888,721 | 331,066 | I |
| 2026-09-01 | Sale : show line 5 in the form 10b5-1 | −3,454 | $514.09 | $1,775,676 | 327,612 | I |
| 2026-09-01 | Sale : show line 6 in the form 10b5-1 | −1,620 | $514.98 | $834,272 | 325,992 | I |
| 2026-09-01 | Sale : show line 7 in the form 10b5-1 | −1,469 | $516.03 | $758,049 | 324,523 | I |
| 2026-09-01 | Sale : show line 8 in the form 10b5-1 | −80 | $516.62 | $41,330 | 324,443 | I |
| Open-market sales · 9,500 sh · avg $514.09 · $4,883,839 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-09-01 | Exercise or conversion : show line 9 in the form 10b5-1 Stock Option | −9,500 | 18,410 | I |
Loading xslF345X06/primarydocument.xml…